Immunomedics, Inc., (Nasdaq: IMMU) today reported a stabilization of disease, as measured by computed tomography (CT) according to RECIST criteria ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE